In the context of an aging society and the challenges posed by the COVID-19 pandemic, ensuring a healthy life expectancy has become a pressing social concern. Amidst the pandemic's impact on medical systems worldwide, the need for advancements in early diagnosis, minimally invasive treatments, and infectious disease countermeasures has been reaffirmed. The demand for practical solutions, including new drugs, medical devices, and healthcare systems, is vocalized by healthcare professionals. To address these challenges, engineering researchers play a crucial role in swiftly translating their technological innovations into medical applications.
In this book, cutting-edge researchers introduce biomedical engineering from materials, devices, imaging, and information. The chapter contributors are major members of the Research Center for Biomedical Engineering, Japan. This text discusses topics on biomaterials (Chapters 1 to 3), medical devices (Chapters 4 to 11), basic medicine and dentistry (Chapters 12 to 15), and medical systems (Chapters 16 and 17). All of the topics are important areas in biomedical engineering.
"synopsis" may belong to another edition of this title.
Akihiro Miyauchi is a professor at the Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Japan. He received his PhD from Tokyo Institute of Technology, Japan, in 1995. With a wealth of experience, he served at Hitachi Ltd from 1986 to 2017 and held the position of visiting scientist at the Massachusetts Institute of Technology from 1995 to 1996. Prof. Miyauchi’s research focuses on semiconductor process, nanoimprint, and biomimetics.
Hiroyuki Kagechika is a professor and director at the Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University. He received his PhD in pharmaceutical sciences from the University of Tokyo, Japan, in 1989. Prof. Kagechika’s major research interest is in the development of functional organic molecules in the fields of medicinal chemistry, chemical biology, and materials sciences. He has developed various novel bioactive compounds, including a drug for acute promyelocytic leukemia.
"About this title" may belong to another edition of this title.
Seller: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Seller Inventory # ABBB-59267
Seller: Basi6 International, Irving, TX, U.S.A.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEOCT25-265256
Seller: SMASS Sellers, IRVING, TX, U.S.A.
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. Seller Inventory # SNTA-59267
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New. Seller Inventory # 47212702-n
Quantity: 10 available
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. 1st edition NO-PA16APR2015-KAP. Seller Inventory # 26399408263
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 47212702-n
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # GB-9789815129168
Quantity: 1 available
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Seller Inventory # 398050136
Quantity: 4 available
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # GB-9789815129168
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition. Seller Inventory # 47212702